From HPO
Hereditary myoglobinuria- MedGen UID:
- 44557
- •Concept ID:
- C0027080
- •
- Finding
Presence of myoglobin in the urine.
Hypotension- MedGen UID:
- 5715
- •Concept ID:
- C0020649
- •
- Finding
Low Blood Pressure, vascular hypotension.
Tachycardia- MedGen UID:
- 21453
- •Concept ID:
- C0039231
- •
- Finding
A rapid heartrate that exceeds the range of the normal resting heartrate for age.
Abnormality of the coagulation cascade- MedGen UID:
- 604
- •Concept ID:
- C0005779
- •
- Disease or Syndrome
An abnormality of the coagulation cascade, which is comprised of the contact activation pathway (also known as the intrinsic pathway) and the tissue factor pathway (also known as the extrinsic pathway) as well as cofactors and regulators.
Rigidity- MedGen UID:
- 7752
- •Concept ID:
- C0026837
- •
- Sign or Symptom
Continuous involuntary sustained muscle contraction. When an affected muscle is passively stretched, the degree of resistance remains constant regardless of the rate at which the muscle is stretched. This feature helps to distinguish rigidity from muscle spasticity.
Rhabdomyolysis- MedGen UID:
- 19775
- •Concept ID:
- C0035410
- •
- Pathologic Function
Breakdown of muscle fibers that leads to the release of muscle fiber contents (myoglobin) into the bloodstream.
Hyperkalemia- MedGen UID:
- 5691
- •Concept ID:
- C0020461
- •
- Finding
An abnormally increased potassium concentration in the blood.
Malignant hyperthermia of anesthesia- MedGen UID:
- 9867
- •Concept ID:
- C0024591
- •
- Injury or Poisoning
Malignant hyperthermia susceptibility (MHS) is a pharmacogenetic disorder of skeletal muscle calcium regulation associated with uncontrolled skeletal muscle hypermetabolism. Manifestations of malignant hyperthermia (MH) are precipitated by certain volatile anesthetics (i.e., halothane, isoflurane, sevoflurane, desflurane, enflurane), either alone or in conjunction with a depolarizing muscle relaxant (specifically, succinylcholine). The triggering substances cause uncontrolled release of calcium from the sarcoplasmic reticulum and may promote entry of extracellular calcium into the myoplasm, causing contracture of skeletal muscles, glycogenolysis, and increased cellular metabolism, resulting in production of heat and excess lactate. Affected individuals experience acidosis, hypercapnia, tachycardia, hyperthermia, muscle rigidity, compartment syndrome, rhabdomyolysis with subsequent increase in serum creatine kinase (CK) concentration, hyperkalemia with a risk for cardiac arrhythmia or even cardiac arrest, and myoglobinuria with a risk for renal failure. In nearly all cases, the first manifestations of MH (tachycardia and tachypnea) occur in the operating room; however, MH may also occur in the early postoperative period. There is mounting evidence that some individuals with MHS will also develop MH with exercise and/or on exposure to hot environments. Without proper and prompt treatment with dantrolene sodium, mortality is extremely high.
Hyperphosphatemia- MedGen UID:
- 39326
- •Concept ID:
- C0085681
- •
- Disease or Syndrome
An abnormally increased phosphate concentration in the blood.
Elevated circulating creatine kinase concentration- MedGen UID:
- 69128
- •Concept ID:
- C0241005
- •
- Finding
An elevation of the level of the enzyme creatine kinase (also known as creatine phosphokinase (CK; EC 2.7.3.2) in the blood. CK levels can be elevated in a number of clinical disorders such as myocardial infarction, rhabdomyolysis, and muscular dystrophy.
Mixed respiratory and metabolic acidosis- MedGen UID:
- 333546
- •Concept ID:
- C1840372
- •
- Finding
- Abnormality of blood and blood-forming tissues
- Abnormality of metabolism/homeostasis
- Abnormality of the cardiovascular system
- Abnormality of the genitourinary system
- Abnormality of the musculoskeletal system